Fig. 1 · Structure
Documents & Downloads
HC-258
Antitumor
HC-258 is an antitumor compound that functions by selectively binding to the cysteine residue within the PA pocket of TEAD. This interaction effectively reduces the expression levels of CTGF, CYR61, AXL, and NF2, while also inhibiting the migratory ability of MDA-MB-231 breast cancer cells. HC-258 serves as a valuable tool for research in cancer biology and therapeutic development.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| CAS Number | 3056128-12-9 |
| Applications | Antitumor |
| Formula | C20H24N2O2 |
| Molecular Weight | 324.42 |
| SMILES | C=CC(NC1=CC=CC(NC2=CC=CC(OCCCCC)=C2)=C1)=O |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.